Medika d.d. operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medika d.d. with three other
drug stores in Europe:
sales of 516.80 million Euros [US$613.05 million]
of which 90%
was SPECIALTY-PHARMA TRADE),
Clinigen Group PLC
of UNITED KINGDOM
(£456.90 million [US$600.39 million]
of which 45%
was Unlicensed Medicines), and
Sopharma Trading AD
based in BULGARIA
(958.69 million Bulgarian Levas [US$581.38 million]
Medika d.d. reported sales of 3.65 billion Croatian Kunas (US$570.92 million)
December of 2019.
increase of 18.2%
versus 2018, when the company's sales were 3.09 billion Croatian Kunas.
Sales at Medika d.d. have increased during each of the previous five years
(and since 2014, sales have increased a total of 60%).